These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6640829)

  • 1. Optimum scheduling during combination chemotherapy of murine leukemia. Additional examples of schedule-dependent synergism between S-phase-specific antimetabolites and agents inducing mitotic or pre-mitotic (G2) arrest.
    Sirotnak FM; Schmid FA; Temple C; Montgomery JA
    Cancer Chemother Pharmacol; 1983; 11(3):205-7. PubMed ID: 6640829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of a schedule-dependent therapeutic synergism utilizing the interacting drugs methotrexate and teniposide in L1210 leukemia.
    Wampler GL; Carter WH; Campbell ED; Goldman ID
    Cancer Treat Rep; 1987 Jun; 71(6):581-91. PubMed ID: 3581096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased schedule-dependent synergism of vindesine versus vincristine in combination with methotrexate against L1210 leukemia.
    Chello PL; Sirotnak FM
    Cancer Treat Rep; 1981; 65(11-12):1049-53. PubMed ID: 7296551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on the relationship between therapeutic schedule and antitumor effect of etoposide and cytosine arabinoside in murine L1210 leukemia].
    Ooi K; Ohkubo T; Kawasaki H; Sakurai M
    Yakugaku Zasshi; 1989 Nov; 109(11):865-8. PubMed ID: 2614669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of 2-chloro-2'-deoxyadenosine alone and in combination with cyclophosphamide or methotrexate on murine leukemia L1210.
    Góra-Tybor J; Robak T; Warzocha K; Grieb P
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):39-42. PubMed ID: 7503633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. R17934-NSC238159: a new antitumor drug--II. Effect on mitotic cycle of L1210 leukemia cells in vivo and synergism with cytosine arabinoside (NSC63878).
    Atassi G; Schaus C; Tagnon HJ
    Eur J Cancer (1965); 1975 Sep; 11(9):609-14. PubMed ID: 1220976
    [No Abstract]   [Full Text] [Related]  

  • 7. Timing- and sequence-dependent synergism between etoposide and methotrexate or etoposide, methotrexate and 5-fluorouracil in advanced leukemia L1210.
    Osswald H; Herrmann R; Youssef M
    Cancer Lett; 1985 Dec; 29(3):277-82. PubMed ID: 4075296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
    Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
    Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of mitotic cycle inhibitors on the antileukemic activity of cytosine arabinoside (NSC-63878) in mice bearing leukemia L1210.
    Vadlamudi S; Goldin A
    Cancer Chemother Rep; 1971 Dec; 55(5):547-55. PubMed ID: 5159846
    [No Abstract]   [Full Text] [Related]  

  • 10. Schedule-dependent synergism of methotrexate and vincristine against murine L1210 leukemia.
    Chello PL; Sirotnak FM; Dorick DM; Moccio DM
    Cancer Treat Rep; 1979; 63(11-12):1889-94. PubMed ID: 526921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deveopment of resistance to combinations of six antimetabolites in mice with L1210 leukemia.
    Schmid FA; Hutchison DJ; Otter GM; Stock CC
    Cancer Treat Rep; 1976 Jan; 60(1):23-7. PubMed ID: 1000516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of cytosine arabinoside toxicity by 3-deazauridine in a murine leukemia model.
    Grem JL; Plowman J; Rubinstein L; Hawkins MJ; Harrison SD
    Leuk Res; 1991; 15(4):229-36. PubMed ID: 2030604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of methotrexate on the leukemic cell cycle in mouse ascitic leukemia L1210].
    Goncharova SA; Frankfurt OS
    Tsitologiia; 1975 Sep; 17(9):1051-6. PubMed ID: 1166521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-related synergism of cytosine arabinoside and methotrexate against murine leukemia L1210.
    Avery TL; Roberts D
    Eur J Cancer (1965); 1974 Jul; 10(7):425-9. PubMed ID: 4457345
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of the stage of advancement of leukemia L1210 in mice on the optimal schedule of treatment of cytosine arabinoside (NSC-63878).
    Kline I; Woodman RJ; Gang M; Sirica A; Venditti JM; Goldin A
    Cancer Chemother Rep; 1972 Jun; 56(3):327-34. PubMed ID: 19051491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cellular mechanism of the antileukemic action of quinoline dibromide].
    Golenko OD; Paramonova TD; Nikolaeva TG
    Biull Eksp Biol Med; 1984 Jul; 98(7):59-61. PubMed ID: 6466833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined effect of HO-221 with various antitumor agents against L 1210 leukemia].
    Nakajima T; Masuda H; Okamoto T; Watanabe M; Yokoyama K; Yamada N; Tsukagoshi S; Taguchi T
    Gan To Kagaku Ryoho; 1991 Apr; 18(4):555-62. PubMed ID: 2012397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schedule-dependent synergism and antagonism between methotrexate and cytarabine against human leukemia cell lines in vitro.
    Akutsu M; Furukawa Y; Tsunoda S; Izumi T; Ohmine K; Kano Y
    Leukemia; 2002 Sep; 16(9):1808-17. PubMed ID: 12200697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-application of arsenic trioxide may potentiate cytotoxic effects of vinorelbine/docetaxel on neuroblastoma SK-N-SH cells.
    Qi K; Li Y; Huang K; Xiong X; Chuchu F; Zhang C; Weng W
    Biomed Pharmacother; 2019 May; 113():108665. PubMed ID: 30889490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in glycosylation of L1210 cells after exposure to various antimetabolites.
    De Graaf TW; Slot SS; Peters GJ; Van Dijk W
    Eur J Cancer; 1993; 29A(12):1760-5. PubMed ID: 8398306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.